The ethnomedicinal function of several cucurbit species (cucumber, squash, melon, gourd, etc.) on diseases (i.e. diabetes, microbial infections, cancer, etc.), and as free radical scavengers have been reported. However, there remains infinitesimal record on citron watermelon broad use, which reflects the reason for wide oversight of underutilization, from lack of recognition for functional food crop development and commercialization. The objective of this study focus towards identifying the natural phytochemicals of C. lanatus on water melon molecules online database for insilico computational approach to screened for suitable antidiabetic lead, and construction of phylogenetic relatedness of target Type 2 Diabetes Mellitus proteins was conducted to predict reoccurrence of insilico analysis output with other homologous target proteins. The T2DM protein targets, phytochemical and standard inhibitory drugs are mined from different databases. Insilico docking analysis, and adme/toxicity profiling was virtually screened for the best fit. In additionally, phylogenetic relationship of the target proteins was aligned and construction with other homologous protein targets to predict the reoccurrence confidence of results on compounds. Seventeen phytochemicals out of the nineteen potential drug candidates substantially passed the profiling test. Also, homologous protein targets with > 90% bootstrap confidence are likely to produce a reoccurring insilico result. Thus, these phytochemicals fulfil all the enlisted criteria and it is suggestively determined to be suitable for the development of potent antidiabetic drugs. It is evident that phytochemicals from Citrullus lanatus produced satisfactory insilico output, and this reflect it to be a probable reservoir containing other potential therapeutic drug candidates for antidiabetic drug discovery and development. Additionally, derivatives can be developed for further effective screening result.
The prevalence of cancer and diabetes has been a major global threat that has led to the continuous investigation of numerous biomarker that can serve in novel therapeutic targets for their treatment. Recently, epigenetic regulatory function of EZH2-PPAR was discovered to influence the metabolic and signaling pathway causing this disease. Hence, the synergistic combination of inhibitors like GSK126 and Bezafibrate was reported have promising outcome for these disease treatment, but without clear understanding of other biomarker association and side effect detriment. The disease association and protein interaction networks between EZH2-PPARs and other biomarkers regulating pancreatic cancer and diabetes pathology were identified, with obesity, and hypertensive disease being the closest vast connection. Natural compounds employed in the molecular docking, adme/toxicity and reactivity screening for candidate inhibitor of versatile capacity against the target identify nine compounds as lead hits. Overall, Phytocassane A exhibit the most recognizable insilico validation for drug likeness profiles better than the standards, and all nine compounds were conclusively proposed for further experimental screening to compliment this finding on their benefit in drug development for diabetes and cancer therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.